
	Gale Encyclopedia of Cancer : Busulfan $3.10	The effects of busulfan (1,4-(Dimethanesulfonoxy) Butane) and butylated hydroxy toluene on the cell cycle of human leukocytes grown in tissue culture

	Studies on transformed leucocytes: Morphology, deoxyribonucleic acid synthesis, and effects of busulfan (1,4-(Dimethanesulfonoxy) Butane)


Busulfan Definition Busulfan (also known by the brand name Myleran) is a chemotherapy medicine used to treat cancer by destroying cancerous cells. From Gale Encyclopedia of Cancer, by RPh. Nancy J. Beaulieu, BCOP

Vinorelbine induced interstitial pneumonitis: a case report INTRODUCTION: Vinorelbine (Navalbine), a newer Vinca alkaloid has been increasingly used in the chemotherapy of non-small-cell Bronchogenic carcinoma ... From CHEST, 10/1/05 by Mayank Vats

Liver Biopsy Findings Following Donor Lymphocyte Infusion We present a case of a 49-year-old man previously diagnosed with chronic myelogenous leukemia. His bone marrow biopsy showed a complex triple translocation ... From Archives of Pathology & Laboratory Medicine, 8/1/05 by Wu, Shou-Jin

Pretransplant Lung Function, Respiratory Failure, and Mortality after Stem Cell Transplantation Rationale: The role of pulmonary function before stem cell transplant as a potential risk factor for the development of early post-transplant respiratory ... From American Journal of Respiratory and Critical Care Medicine, 8/1/05 by Parimon, Tanyalak

Lymphadenopathy in a 3-Year-Old Boy 17 Months After Bone Marrow Transplantation for Acute Myeloid Leukemia (AML-M5a) A 3-year-old boy initially presented with fever, refusal to walk, night sweats, and pancytopenia. He was diagnosed with acute monoblastic leukemia (AML-MSa) ... From Archives of Pathology & Laboratory Medicine, 7/1/05 by Turyan, Hach V

Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia Study objectives: Reported risk factors for bronchiolitis obliterans (BO) in allogeneic hematopoietic stem-cell transplant recipients come from modest-sized ... From CHEST, 7/1/05 by Linus H. Santo Tomas

Prevalence and reversibility of pulmonary dysfunction in refractory systemic lupus : improvement correlates with disease remission following hematopoietic Aim: To report the prevalence and reversibility of pulmonary function test (PFT) abnormalities among systemic lupus erythematosus (SLE) patients, refractory ... From CHEST, 5/1/05 by Ann E. Traynor

Chronic Myelocytic Leukemia - Part II: Approaches to and Molecular Monitoring of Therapy DATA SOURCES: Current literature. DATA SYNTHESIS: Chronic myelocytic leukemia (CML) was initially described in 1845 and is considered one of the first ... From Clinical Laboratory Science, 1/1/05 by Randolph, Tim R

Home

Contact

Resources

Exchange Links

ebay